Condition
IBD (Inflammatory Bowel Disease) clinical trials and research
As of November 12, 2026, Find a Trial lists 22 IBD (Inflammatory Bowel Disease) clinical trials that are recruiting, at sites in 9 countries (most in China (7), Canada (4), Italy (3)). By phase: Phase 1 (2), Phase 2/3 (1), Phase 4 (1). The most active sponsors are Changhai Hospital (4), University of British Columbia (4), Children's Hospital Medical Center, Cincinnati (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 22Clinical trials
- 9Countries
Newest IBD (Inflammatory Bowel Disease) clinical trials
All recruiting trials (22)
-
Melatonin to improve sleep quality in adults with inflammatory bowel disease in remission
This study tests whether melatonin can improve sleep quality in adults with IBD who are in clinical remission.
-
Individualizing Anti-TNF Therapy in IBD
This study tests whether genetic markers can predict which anti-TNF–naïve IBD patients will respond to their first anti-TNF treatment.
-
BDHK-2009 safety test in healthy adults
This early-stage test checks if BDHK-2009 tablets are safe and tolerable in healthy adults aged 18–55 compared with placebo.
-
Infliximab level monitoring in children with inflammatory bowel disease
This project will test whether measuring infliximab levels in saliva and leftover blood during the first infusions helps monitor and personalize treatment for children and teens (ages 3–18) with Crohn's disease or ulcerative colitis.
-
Guselkumab vs Ustekinumab for stricturing Crohn's disease
This study will follow adults with moderate-to-severe Crohn's disease and confirmed intestinal strictures to see if treatment with guselkumab or ustekinumab better controls obstructive symptoms and disease activity.
-
Maternal and infant microbiome links to infant gut inflammation and pregnancy outcomes in people with IBD
This project will see if mothers' microbiomes, diets, and breastmilk are linked to infant gut inflammation (measured by fecal calprotectin) in pregnant people with and without IBD.
-
Maternal and infant microbiome links to infant gut inflammation and pregnancy outcomes in people with IBD
This project will see if mothers' microbiomes, diets, and breastmilk are linked to infant gut inflammation (measured by fecal calprotectin) in pregnant people with and without IBD.
-
Phase 1 testing of HW201877 in healthy adults
This test will try HW201877 in healthy adults to see if it is safe, how well people tolerate it, and how their bodies process the drug.
-
Pre-packaged low-residue diet (Maifu Changqing®) for bowel preparation in adults with IBD
This project will see if a pre-packaged low-residue nutrition powder (Maifu Changqing®) makes bowel preparation easier and better nourishes adults with IBD who are having a colonoscopy.
-
Improving bowel preparation for colonoscopy in people with IBD
This project will test whether current bowel-prep practices and individual patient factors affect how clean the bowel is for people with IBD having a colonoscopy.
-
Infliximab plus the Crohn's Disease Exclusion Diet for children with Crohn's disease
This will test whether starting a Crohn's Disease Exclusion Diet at the same time as infliximab helps children with moderate-to-severe Crohn's disease get better and stay in remission.
-
Infliximab plus the Crohn's Disease Exclusion Diet for children with Crohn's disease
This will test whether starting a Crohn's Disease Exclusion Diet at the same time as infliximab helps children with moderate-to-severe Crohn's disease get better and stay in remission.
-
Robotic versus laparoscopic colorectal surgery for people with IBD
Adults with IBD who need elective colorectal surgery will be randomly assigned to robotic or conventional laparoscopic surgery to see if robotic surgery reduces complications and improves recovery and quality of life.
-
SMART-IBD app for teens with inflammatory bowel disease
This will test whether the SMART-IBD smartphone app helps adolescents ages 13–17 with IBD take their medicines and manage symptoms better than completing daily diaries alone.
-
SMART-IBD app for teens with inflammatory bowel disease
This will test whether the SMART-IBD smartphone app helps adolescents ages 13–17 with IBD take their medicines and manage symptoms better than completing daily diaries alone.
-
Combining diet and stress-management with advanced treatments for Crohn's and ulcerative colitis
This study will test whether adding diet guidance and stress-management support to advanced IBD medications helps people with active Crohn's disease or ulcerative colitis achieve and maintain remission.
-
Pre-Packaged Low-Residue Diet for Bowel Prep in IBD Patients
This study tests whether a pre-packaged low-residue diet, Maifu Changqing Complete Nutritional Formula Powder, helps bowel prep for colonoscopy in people with inflammatory bowel disease.
-
Probiotic 6600 as an add-on treatment for ulcerative colitis, Crohn's disease, and colitis
This trial will test whether adding Probiotic 6600 to usual care helps adults with ulcerative colitis, Crohn's disease, or nonspecific colitis reach clinical remission over 24 weeks.
-
Identifying triggers of IBD flare-ups
This study is trying to find out what causes flare-ups in people with Inflammatory Bowel Disease by looking at their samples and surveys to help improve treatment options.
-
Intensified omeprazole treatment to reduce high-output stoma in ileostomy patients
This study tests if a stronger dose of omeprazole can help adults with ileostomy surgery have less stoma output and stay out of the hospital longer.
-
Monitoring patients with inflammatory bowel diseases in Emilia-Romagna
This study looks at people with inflammatory bowel diseases to see what factors might lead to more serious health issues and how medications and surgeries affect their quality of life over ten years.
-
Observational study on therapies for Inflammatory Bowel Disease
This study is testing new treatments for people with Inflammatory Bowel Disease who haven't had success with previous therapies to see how well they work.
Related topics
Quick answers
How many IBD (Inflammatory Bowel Disease) clinical trials are recruiting right now?
22, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 9 countries. The most sites are in China (7 trials), Canada (4 trials), Italy (3 trials), United States (3 trials), Poland (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2, Phase 2/3: 1, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.